本页面由Tiger Trade Technology Pte. Ltd.提供服务

Revolution Medicines, Inc.

193.95
+4.192.21%
盘前:193.00-0.9500-0.49%06:00 EDT
成交量:166.74万
成交额:3.20亿
市值:415.71亿
市盈率:-21.74
高:194.26
开:187.79
低:184.76
收:189.76
52周最高:224.31
52周最低:47.45
股本:2.14亿
流通股本:1.85亿
量比:0.74
换手率:0.90%
股息:- -
股息率:- -
每股收益(TTM):-8.9212
每股收益(LYR):-5.9502
净资产收益率:-79.09%
总资产收益率:-30.12%
市净率:15.95
市盈率(LYR):-32.60

数据加载中...

2026/02/25

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/25

重要事件披露

Form 8-K - Current report
2026/02/25

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities